Trial Profile
Effects of atorvastatin versus rosuvastatin in patients with mild coronary atherosclerotic plaques (ARTMAP Trial)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 May 2012
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Rosuvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms ARTMAP
- 30 May 2012 New trial record